tiprankstipranks
Cyclo Therapeutics (CYTH)
NASDAQ:CYTH
US Market

Cyclo Therapeutics (CYTH) Technical Analysis

189 Followers

Technical Sentiment

Overall Consensus
Sell
4Bullish
4Neutral
14Bearish
Technical Analysis Consensus
Buy
4Bullish
4Neutral
2Bearish
Moving Average Consensus
Strong Sell
0Bullish
0Neutral
12Bearish
Cyclo Therapeutics’s (CYTH) Moving Averages Convergence Divergence (MACD) indicator is -0.01, suggesting Cyclo Therapeutics is a Buy.
Cyclo Therapeutics’s (CYTH) 20-Day exponential moving average is 1.26, while Cyclo Therapeutics’s (CYTH) share price is $1.17, making it a Sell.
Cyclo Therapeutics’s (CYTH) 50-Day exponential moving average is 1.29, while Cyclo Therapeutics’s (CYTH) share price is $1.17, making it a Sell.

Cyclo Therapeutics (CYTH) Pivot Points

Jul 22, 2024, 04:08 PM
Name
S3
S2
S1
Pivot Points
R1
R2
R3
Classic
1.15
1.18
1.19
1.21
1.22
1.25
1.26
Fibonacci
1.18
1.19
1.20
1.21
1.23
1.24
1.25
Pivot points are a technical analysis tool used by traders to identify potential support and resistance levels in financial markets. Pivot points are calculated based on the previous day's high, low, and close prices, and are used to help traders identify levels at which the price may reverse or continue to trend.

Cyclo Therapeutics (CYTH) Moving Averages

Jul 22, 2024, 04:08 PM
Period
Simple
Exponential
MA5
1.22Sell
1.23Sell
MA10
1.28Sell
1.25Sell
MA20
1.25Sell
1.26Sell
MA50
1.29Sell
1.29Sell
MA100
1.37Sell
1.35Sell
MA200
1.40Sell
1.39Sell
Cyclo Therapeutics’s (CYTH) 10-Day exponential moving average is 1.25, while Cyclo Therapeutics’s (CYTH) share price is $1.17, making it a Sell.
Cyclo Therapeutics’s (CYTH) 100-Day exponential moving average is 1.35, while Cyclo Therapeutics’s (CYTH) share price is $1.17, making it a Sell.
Cyclo Therapeutics’s (CYTH) stock price is $1.17 and Cyclo Therapeutics’s (CYTH) 50-day simple moving average is 1.29, creating a Sell signal.
Cyclo Therapeutics’s (CYTH) stock price is $1.17 and Cyclo Therapeutics’s (CYTH) 100-day simple moving average is 1.37, creating a Sell signal.
Cyclo Therapeutics’s (CYTH) stock price is $1.17 and Cyclo Therapeutics’s (CYTH) 200-day simple moving average is 1.40, creating a Sell signal.

Cyclo Therapeutics (CYTH) Technical Indicators

Jul 22, 2024, 04:08 PM
Name
Value
Implied Action
RSI (14)
45.15
Neutral
STOCH (9,6)
11.73
Buy
STOCHRSI (14)
21.20
Neutral
MACD (12,26)
-0.01
Buy
ADX (14)
12.10
Buy
Williams %R
-94.97
Buy
CCI (14)
-65.74
Neutral
ATR (14)
0.08
-
Ultimate Oscillator
41.35
Neutral
ROC
-4.72
Sell
Cyclo Therapeutics’s (CYTH) Relative Strength Index (RSI) is 45.15, creating a Neutral signal.
Cyclo Therapeutics’s (CYTH) Trend Strength Indicator (ADX) is 12.10, creating a Buy signal.
Cyclo Therapeutics’s (CYTH) Commodity Channel Index (CCI) is -65.74, creating a Neutral signal.
Cyclo Therapeutics’s (CYTH) Price Rate of Change (ROC) is -4.72, creating a Sell signal.

FAQ

Is CYTH a Buy, Hold, or Sell?
Based on CYTH’s technical indicators, CYTH is a Sell.
    What is CYTH’s RSI (14)?
    CYTH’s RSI (14) is 45.15, which suggests CYTH is a Neutral.
      What is CYTH’s MACD?
      CYTH’s MACD is -0.01, which suggests CYTH is a Buy.
        What is CYTH’s 5-day moving average?
        CYTH’s 5-day moving average is 1.22, which suggests CYTH is a Sell.
          What is CYTH’s 20-day moving average?
          CYTH 20-day moving average is 1.25, which suggests CYTH is a Sell.
            What is CYTH’s 50-day moving average?
            CYTH’s 50-day moving average is 1.29, which suggests CYTH is a Sell.
              What is CYTH’s 200-day moving average?
              CYTH’s 200-day moving average is 1.40, which suggests CYTH is a Sell.
                What is CYTH’s Williams % R (14)?
                CYTH’s Williams % R (14) is -94.97, which suggests CYTH is a Buy.
                  What is CYTH’s CCI (14)?
                  CYTH’s CCI (14) is -65.74, which suggests CYTH is a Neutral.
                    What's Included in PREMIUM?
                    Make informed decisions based on Top Analysts' activity
                    Know what industry insiders are buying
                    Get actionable alerts from top Wall Street Analysts
                    Find out before anyone else which stock is going to shoot up
                    Get powerful stock screeners & detailed portfolio analysis